If you’re into Peptides, this Conference is going to be AMAZING!!!
Lots of MONSTER NAMES in this lineup. This is literally the WHO’s WHO of the peptide world.
This conference is going to be very unique in that it will cover the legislative,
PCAC results, evidence gap, regulation, compounding, the problem with the current medical system, human performance (enhancing), hormones & metabolic health, reach and responsibility, establishing manufacturing in the US, STEM CELLS, veteran/military care and so much more.
I’ll be speaking on Day 2, discussing peptides and the immune system.
Date: September 17-18
Location: Four Seasons, Washington D.C.
🎟️ Grab your pass: https://t.co/8yPAMGmwXo
@AbudBakri@ferrisbuhler81@lillyobeach@DrAlexTatem@DrHalMDMBA@1ConciergeMed@LeeRosebush@thegarybrecka@bengreenfield@byurth
INTRODUCING: The PEPTIDES for Veterans Act.
Our veterans carry the physical and mental toll of their service long after they take off the uniform. Chronic pain, service-related injuries and mental health struggles too often go untreated. Meanwhile, peptide-based therapies have shown real promise in recovery, rehabilitation, chronic pain management and mental wellness.
Our bill directs the VA to modernize its definitions, review the latest research, and conduct a real study on the safety and benefits of peptide-based therapies for veterans. If the science supports it, the bill establishes a pilot program to get these therapies into VA medical facilities for veterans who choose to participate.
This is not just Making America Healthy Again in action, it is making our veterans healthy again, cutting through outdated bureaucracy and giving our veterans access to real, evidence-based options for healing.
Our veterans signed up to protect this country. The least we can do is make sure they have every tool available to heal from it.
Gary Brecka and his team have put thousands of people on oral BPC-157.
None of them had any adverse effects.
- healed stomach ulcers and IBD lesions
- measurable gut-healing in 3–5 days
- almost completely blocked stomach damage from ibuprofen
- 36 studies reviewed by the American College of Gastroenterology
Current data is mostly in animals and the human evidence is anecdotal, but it's hard to ignore what we keep seeing.
As many of you know, Professor Skiric is a part of American sciences.
I sat in on one of his lectures one time and was surprised to learn about the benefits for corneal healing with BPC administered topically. Topical BPC isn’t discussed enough.. that’s why we have topical BPC in two blends
#peptides #BPC157
Personalized mRNA cancer vaccines are having a very interesting week.
Days after the first positive Phase III mRNA cancer vaccine readout in melanoma, BioNTech is discontinuing its Phase II colorectal cancer study for futility.
Same broad platform. Very different tumors. Very different outcome.
A good reminder that the future of precision oncology probably won’t be defined by whether a technology “works” — but where, when and in which biological context it works.
@DrJesseMorse Just looked into it more, I think it has to do with the glucose levels and dehydration.
Either way would be interested to see if SS-31 could make my eyesight even better🤔
$ARGX up 15% after encouraging Vyvgart data in inflammatory muscle disease, with statistically significant results in IMNM — a condition with no specifically approved therapies in the U.S.
Another example of how autoimmune drug platforms can create massive value by expanding into underserved indications.
BPC-157 and acemannan are interesting for different reasons.
BPC-157 research → angiogenesis/VEGF signaling, tissue repair, GI protection
Acemannan research → immune modulation, fibroblast activity, collagen production, wound healing
Put simply: BPC-157 may help coordinate the repair response. Acemannan may help support the cellular environment doing the rebuilding.
One is a small protein molecule and one is a large polysaccharide, but a lot of biological overlap.
#peptides #peptideresearch